ChemoMetec A/S reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was DKK 199.28 million compared to DKK 240.6 million a year ago. Net income was DKK 70.56 million compared to DKK 105.42 million a year ago.

Basic earnings per share from continuing operations was DKK 4.05 compared to DKK 6.06 a year ago. Diluted earnings per share from continuing operations was DKK 4.05 compared to DKK 6.06 a year ago.